Aveanna Healthcare Holdings, INC 8-K filings

Aveanna Healthcare Holdings Inc. provided an investor presentation on August 13, 2026, detailing its 2026 guidance, key operating statistics, and strategic focus on organic growth, value-based care, and acquisitions.

Aveanna Healthcare Holdings Inc. reported a significant increase in second-quarter revenue and net income, alongside a substantial raise in its full-year 2026 financial guidance for both revenue and Adjusted EBITDA.

Aveanna Healthcare Holdings Inc. announced the immediate resignation of director Dr. Erica Schwartz, who has been nominated to lead the U.S. Centers for Disease Control and Prevention.

Aveanna Healthcare Holdings Inc. has finalized its acquisition of Family First Holding, LLC for $175.5 million and updated its full-year 2026 financial guidance.

Aveanna Healthcare Holdings Inc. reports the successful election of directors and ratification of auditors at its 2026 Annual Meeting.

Aveanna Healthcare has successfully repriced its credit facilities, securing a 50 basis point reduction in interest rate margins.

Aveanna Healthcare Holdings Inc. released an investor presentation on May 15, 2026, detailing its 2026 guidance, segment performance, and strategic priorities.

Aveanna Healthcare Holdings Inc. reported a significant increase in first-quarter revenue and net income, alongside an upward revision of its full-year 2026 financial guidance.

Aveanna Healthcare Holdings Inc. presented a financial overview to investors, highlighting robust Q4 2025 performance and outlining strategic growth initiatives for 2026.

Aveanna Healthcare Holdings Inc. announced significantly improved fourth quarter and full year 2025 financial results, alongside maintaining its 2026 guidance and revealing a new acquisition.

Aveanna Healthcare Holdings Inc. announced an agreement to acquire Family First Homecare for $175.5 million, expanding its pediatric home care services.

Robert M. Williams, Jr. has resigned from the Board of Directors of Aveanna Healthcare Holdings Inc., effective immediately, with no reported disagreements.

Aveanna Healthcare Holdings Inc. updated its full year 2025 financial guidance upwards and provided initial full year 2026 guidance, reflecting strong operational performance.

Aveanna Healthcare Holdings Inc. updated its shareholder agreement to restrict executive stock transfers and appointed Bain Capital Principal Sam Weil to its Board of Directors.

Aveanna Healthcare Holdings Inc. reports robust Q3 2025 financial performance and outlines its transformative homecare platform and long-term growth strategy.

Aveanna Healthcare Holdings Inc. reported strong third-quarter 2025 financial results, including significant revenue and Adjusted EBITDA growth, and raised its full-year 2025 guidance.

Aveanna Healthcare Holdings Inc. announced a secondary offering where certain affiliated selling stockholders sold 10 million shares of common stock at $9.00 per share, with the company receiving no proceeds.

Aveanna Healthcare Holdings Inc. announced preliminary third-quarter 2025 financial results, projecting significant revenue, net income, and Adjusted EBITDA growth.

Aveanna Healthcare Holdings Inc. announced robust Q2 2025 financial results, showcasing significant revenue and Adjusted EBITDA growth, complemented by a successful debt refinancing.

Aveanna Healthcare Holdings Inc. successfully refinanced its first lien credit facility, extending maturities and increasing revolving credit availability to $250 million while repaying its second lien debt.

Aveanna Healthcare Holdings Inc. released an investor presentation highlighting significant Q2 2025 financial performance improvements and reaffirming its 2025 guidance.

Aveanna Healthcare Holdings Inc. reported significant revenue and Adjusted EBITDA growth for Q2 2025, leading to an upward revision of its full-year 2025 financial guidance.

Aveanna Healthcare Holdings Inc. announced a seventh amendment to its Receivables Financing Agreement, increasing the available facility limit to $275 million and extending its scheduled termination date to June 25, 2028.

Aveanna Healthcare Holdings Inc. has successfully completed its acquisition of Thrive Skilled Pediatric Care, expanding its specialized home care services across new and existing states.

Aveanna Healthcare held its 2025 Annual Meeting of Stockholders on May 9, 2025, and announced the voting results for the election of directors, ratification of the appointment of Ernst & Young LLP, and approval of executive compensation.

Aveanna Healthcare highlights its focus on value-based growth, enhanced capital structure, and core organic growth in its May 2025 investor presentation.

Aveanna Healthcare reports a 14.0% increase in first quarter revenue and a 93.1% increase in Adjusted EBITDA, leading to an improved full-year 2025 outlook.

Aveanna Healthcare Holdings Inc. announces an agreement to acquire Thrive Skilled Pediatric Care, LLC for approximately $75 million, primarily in shares of common stock.

Dr. Sheldon Retchin, an independent director at Aveanna Healthcare, resigned from the Board of Directors effective March 27, 2025, due to personal health reasons.

Aveanna Healthcare Holdings Inc. shares its financial presentation to investors, highlighting 2025 guidance and strategic initiatives.